Published in Biochem J on November 15, 1978
How is the level of free arachidonic acid controlled in mammalian cells? Biochem J (1982) 3.96
Regulation of arachidonic acid metabolites in macrophages. J Exp Med (1980) 3.00
Mouse peritoneal macrophages release leukotriene C in response to a phagocytic stimulus. Proc Natl Acad Sci U S A (1980) 2.53
Prostaglandin synthesis by macrophages requires a specific receptor-ligand interaction. Proc Natl Acad Sci U S A (1980) 2.49
Bacterial lipopolysaccharides prime macrophages for enhanced release of arachidonic acid metabolites. J Exp Med (1986) 2.34
Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization. J Clin Invest (1982) 2.33
Dynamics of leukotriene C production by macrophages. J Exp Med (1980) 1.93
Secretion of leukotriene C and other arachidonic acid metabolites by macrophages challenged with immunoglobulin E immune complexes. J Exp Med (1982) 1.73
Regulation of arachidonic acid metabolism by macrophage activation. J Exp Med (1982) 1.69
Synthesis of leukotriene C and other arachidonic acid metabolites by mouse pulmonary macrophages. J Exp Med (1982) 1.54
Resting macrophages produce distinct metabolites from exogenous arachidonic acid. J Exp Med (1982) 1.44
Dietary fish oil modulates macrophage fatty acids and decreases arthritis susceptibility in mice. J Exp Med (1985) 1.41
Primary amines induce selective release of lysosomal enzymes from mouse macrophages. Biochem J (1980) 1.27
Relationship of prostaglandin secretion by rabbit alveolar macrophages to phagocytosis and lysosomal enzyme release. Biochem J (1979) 1.23
A selective defect in arachidonic acid release from macrophage membranes in high potassium media. J Cell Biol (1984) 1.19
Evidence for sequential signals in the induction of the arachidonic acid cascade in macrophages. J Exp Med (1986) 1.17
Candida albicans stimulates arachidonic acid liberation from alveolar macrophages through alpha-mannan and beta-glucan cell wall components. Infect Immun (1994) 1.16
Depletion of glutathione selectively inhibits synthesis of leukotriene C by macrophages. Proc Natl Acad Sci U S A (1981) 1.13
Bacterial lipopolysaccharides, phorbol myristate acetate, and zymosan induce the myristoylation of specific macrophage proteins. Proc Natl Acad Sci U S A (1986) 1.10
Analysis of the nonfunctional respiratory burst in murine Kupffer cells. J Exp Med (1988) 1.10
Lymphocyte traffic through antigen-stimulated lymph nodes. II. Role of Prostaglandin E2 as a mediator of cell shutdown. Immunology (1981) 1.09
[Identification and characterization of two phospholipase A2 activities in resident mouse peritoneal macrophages]. Biochem J (1981) 1.08
Thromboxane synthase is preferentially conserved in activated mouse peritoneal macrophages. J Clin Invest (1985) 1.06
Biosynthesis and transport of lysosomal enzymes in human monocytes and macrophages. Effects of ammonium chloride, zymosan and tunicamycin. Biochem J (1983) 1.03
Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells. J Biol Chem (2009) 1.00
Identification and characterization of a phospholipase C activity in resident mouse peritoneal macrophages. Inhibition of the enzyme by phenothiazines. Biochem J (1981) 0.98
Zymosan-induced glycerylprostaglandin and prostaglandin synthesis in resident peritoneal macrophages: roles of cyclo-oxygenase-1 and -2. Biochem J (2006) 0.97
Activation of human peripheral blood monocytes by lipoproteins. Am J Pathol (1988) 0.96
Retinal pigment epithelial acid lipase activity and lipoprotein receptors: effects of dietary omega-3 fatty acids. Trans Am Ophthalmol Soc (2002) 0.95
Calcium ionophore synergizes with bacterial lipopolysaccharides in activating macrophage arachidonic acid metabolism. J Exp Med (1988) 0.94
Arachidonic acid metabolism in glutathione-deficient macrophages. Proc Natl Acad Sci U S A (1982) 0.91
IgE immune complexes stimulate arachidonic acid release by mouse peritoneal macrophages. Proc Natl Acad Sci U S A (1982) 0.91
Monocyte migration explains the changes in macrophage arachidonate metabolism during the immune response. Proc Natl Acad Sci U S A (1986) 0.90
Regulation of prostaglandin synthesis by protein kinase C in mouse peritoneal macrophages. Biochem J (1989) 0.88
Effect of administration of fibronectin or aprotinin on liver regeneration after experimental hepatectomy. Ann Surg (1990) 0.87
Prostaglandin E2 production by dispersed canine fundic mucosal cells. Contribution of macrophages and endothelial cells as major sources. J Clin Invest (1989) 0.87
The role of prostaglandins in the nociceptive response induced by intraperitoneal injection of zymosan in mice. Br J Pharmacol (1987) 0.85
Stage-dependent reduction in T colony formation in Hodgkin's disease. Coincidence with monocyte synthesis of prostaglandins. J Clin Invest (1980) 0.85
The selective release of phospholipase A2 by resident mouse peritoneal macrophages. Biochem J (1981) 0.85
Arachidonic acid turnover in response to lipopolysaccharide and opsonized zymosan in human monocyte-derived macrophages. Biochem J (1986) 0.85
Acyl-chain selectivity of the 85 kDa phospholipase A2 and of the release process in intact macrophages. Biochem J (1994) 0.84
Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone. J Exp Med (1989) 0.84
Regulation of macrophage eicosanoid production by hydroperoxy-and hydroxy-eicosatetraenoic acids. Biochem J (1986) 0.83
Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma. Clin Exp Immunol (1987) 0.82
The expression of functional IL-2 receptor on activated macrophages depends on the stimulus applied. Immunology (1989) 0.82
Oxidative metabolism of a fatty acid amide hydrolase-regulated lipid, arachidonoyltaurine. Biochemistry (2008) 0.79
Synthetic glycopeptide substrates for receptor-mediated endocytosis by macrophages. Proc Natl Acad Sci U S A (1981) 0.79
Evidence for differential activation of arachidonic acid metabolism in formylpeptide- and macrophage-activation-factor-stimulated guinea-pig macrophages. Biochem J (1985) 0.77
Prostaglandins from Cytosolic Phospholipase A2α/Cyclooxygenase-1 Pathway and Mitogen-activated Protein Kinases Regulate Gene Expression in Candida albicans-infected Macrophages. J Biol Chem (2016) 0.76
The release of prostaglandin and slow reacting substance from mouse macrophages. Agents Actions (1981) 0.75
Dimethyl sulfoxide inhibits zymosan-induced intestinal inflammation and barrier dysfunction. World J Gastroenterol (2015) 0.75
An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature (1976) 13.19
In vitro synthesis and secretion of lysozyme by mononuclear phagocytes. J Exp Med (1974) 7.43
Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature (1977) 4.75
Elastase secretion by stimulated macrophages. Characterization and regulation. J Exp Med (1975) 4.60
Secretion of a specific collagenase by stimulated macrophages. J Exp Med (1975) 4.56
Studies on glucosaminidase. 3. Testicular N-acetyl-beta-glucosaminidase and N-acetyl-beta-galactosaminidase. Biochem J (1961) 3.90
Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory corticosteroids. Proc Natl Acad Sci U S A (1976) 3.62
Control of lymphokine secretion by prostaglandins. Nature (1976) 3.34
2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect. J Exp Med (1976) 2.80
Metabolism of [14C]arachidonic acid by human platelets. Biochim Biophys Acta (1976) 2.61
Macrophage plasminogen activator: induction by products of activated lymphoid cells. J Exp Med (1977) 2.00
Lipids of alveolar macrophages, polymorphonuclear leukocytes, and their phagocytic vesicles. J Clin Invest (1972) 1.84
Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79
Stimulation of prostaglandin synthesis by bradykinin and thrombin and their mechanisms of action on MC5-5 fibroblasts. J Biol Chem (1976) 1.68
The modulation of lymphocyte functions by molecules secreted by macrophages. II. Conditions leading to increased secretion. J Exp Med (1976) 1.30
The macrophage as a secretory cell. Int Rev Cytol (1978) 1.27
Selective incorporation of 14C-arachidonic acid into the phospholipids of intact tissues and subsequent metabolism to 14C-prostaglandins. Prostaglandins (1976) 1.24
Macrophages on intrauterine contraceptive devices produce prostaglandins. Nature (1975) 1.23
The selective release of lysosomal acid hydrolases from mouse peritoneal macrophages by stimuli of chronic inflammation. Br J Exp Pathol (1977) 1.22
Ovulation blockade by aspirin or indomethacin--in vivo evidence for a role of prostaglandin in gonadotrophin secretion. Prostaglandins (1972) 1.15
Macrophage neutral proteinases and defense of the lung. Fed Proc (1977) 1.00
Prostaglandins, cyclic nucleotides and cell function. Prostaglandins (1974) 0.98
Complement metabolism: cellular and humoral regulation. Transplant Rev (1976) 0.93
Prostaglandin production by methylcholanthrene-transformed mouse BALB/3T3: inhibition by cytochalasin B. Prostaglandins (1976) 0.85
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA (2000) 6.55
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet (2000) 6.12
Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet (1976) 6.09
Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70
Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann Neurol (1988) 5.18
Role of contractile microfilaments in macrophage movement and endocytosis. Nat New Biol (1971) 4.82
Macrophages synthesis and release prostaglandins in response to inflammatory stimuli. Nature (1977) 4.75
A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis. Proc Natl Acad Sci U S A (1990) 4.26
The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein. Nature (1999) 3.96
STREPTOMYCES ANTIBIOTICS. III. DEGRADATION OF STREPTOMYCIN TO STREPTOBIOSAMINE DERIVATIVES. Science (1945) 3.59
Regional organisation of neonatal intensive care in the North-west. Br Med J (1979) 3.50
A neuronal antigen in the brains of Alzheimer patients. Science (1986) 3.49
Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol Aging (1992) 3.05
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment. Neurobiol Aging (2005) 3.00
Asbestos induces selective release of lysosomal enzymes from mononuclear phagocytes. Nature (1974) 2.86
Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance. J Exp Med (1974) 2.72
Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res (1997) 2.71
Prostaglandins, arachidonic acid, and inflammation. Science (1980) 2.55
Decreased concentrations of GLUT1 and GLUT3 glucose transporters in the brains of patients with Alzheimer's disease. Ann Neurol (1994) 2.54
Dapsone in rheumatoid arthritis. Rheumatol Rehabil (1976) 2.45
Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques. Am J Pathol (1988) 2.42
Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J Biol Chem (1992) 2.40
Conformational change as one of the earliest alterations of tau in Alzheimer's disease. Neurobiol Aging (2000) 2.40
The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35
A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess (1999) 2.32
Effects of gold, dapsone, and prednisone on serum C-reactive protein and haptoglobin and the erythrocyte sedimentation rate in rheumatoid arthritis. Ann Rheum Dis (1979) 2.30
Mechanism for irreversible self-deactivation of prostaglandin synthetase. J Biol Chem (1976) 2.30
Relation between initial blood pressure and its fall with treatment. Lancet (1985) 2.27
The role of arachidonic acid oxygenation products in pain and inflammation. Annu Rev Immunol (1984) 2.25
The Campbell Collaboration. Does for public policy what cochrane does for health. BMJ (2001) 2.24
The power of the classical twin study. Heredity (Edinb) (1978) 2.23
Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol (1994) 2.23
Communication disorders: planning a service to meet the needs. Br J Disord Commun (1989) 2.22
How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS) Rheumatology (Oxford) (2000) 2.21
Why don't patients turn up? Health Soc Serv J (1984) 2.20
Relationship between production and release of lymphocyte-activating factor (interleukin 1) by murine macrophages. 1. Effects of various agents. Cell Immunol (1981) 2.18
Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis. Adv Cyclic Nucleotide Res (1975) 2.17
Which patients stop working because of rheumatoid arthritis? Results of five years' follow up in 732 patients from the Early RA Study (ERAS). Ann Rheum Dis (2002) 2.11
Inhibition by prostaglandins of leukotriene B4 release from activated neutrophils. Proc Natl Acad Sci U S A (1983) 2.06
Neurotransmitter-related enzymes in senile dementia of the Alzheimer type. Brain Res (1979) 2.04
The biological effects of magnesium-leached chrysotile asbestos. Br J Exp Pathol (1977) 2.03
Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature (1980) 2.02
Mitotic mechanisms in Alzheimer's disease? J Cell Biol (1996) 2.00
STREPTOMYCES ANTIBIOTICS. I. CRYSTALLINE SALTS OF STREPTOMYCIN AND STREPTOTHRICIN. Science (1945) 1.98
A nucleated assembly mechanism of Alzheimer paired helical filaments. Proc Natl Acad Sci U S A (1998) 1.97
Recognition of tau epitopes by anti-neurofilament antibodies that bind to Alzheimer neurofibrillary tangles. Proc Natl Acad Sci U S A (1987) 1.96
Antigen-antibody complexes stimulate the synthesis and release of prostaglandins by mouse peritoneal macrophages. Prostaglandins (1979) 1.95
A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex(®) ), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis. Eur J Neurol (2011) 1.93
The activation of protein kinase C by biologically active lipid moieties of lipopolysaccharide. J Biol Chem (1984) 1.92
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer (2003) 1.90
Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging (1995) 1.90
Risking everything? Risk behavior, behavior change, and AIDS. Science (1994) 1.89
Role of prostaglandin endoperoxide PGG2 in inflammatory processes. Nature (1977) 1.89
The inhibition of phagocytosis and facilitation of exocytosis in rabbit polymorphonuclear leukocytes by cytochalasin B. Lab Invest (1973) 1.89
The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol (1983) 1.88
Phosphonomycin: structure and synthesis. Science (1969) 1.87
Ability of activated complement components to induce lysosomal enzyme release from macrophages. Nature (1976) 1.85
Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes. Neurobiol Dis (2000) 1.84
Resting metabolic rate in homozygous sickle cell disease. Am J Clin Nutr (1993) 1.79
Senile dementia of the Alzheimer type without neocortical neurofibrillary tangles. J Neuropathol Exp Neurol (1987) 1.78
The four biochemically distinct species of human interleukin 1 all exhibit similar biologic activities. J Immunol (1985) 1.78
Significance of the individual components of the Apgar score. Br J Anaesth (1973) 1.76
Acute reactions to urographic contrast media. Br Med J (1975) 1.71
Mechanisms of endocytosis and exocytosis. Symp Soc Exp Biol (1974) 1.69
Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology (1991) 1.69
Paracetamol induced hepatotoxicity. Arch Dis Child (2006) 1.67
Chlamydia pneumoniae and asthma. Thorax (1998) 1.67
Is rheumatoid arthritis becoming less severe? J Chronic Dis (1983) 1.64
Connectivity of an effective hypothalamic surgical target for cluster headache. J Clin Neurosci (2007) 1.64
Immune complexes induce selective release of lysosomal hydrolases from macrophages. Nature (1974) 1.64
The Saccharomyces cerevisiae CCH1 gene is involved in calcium influx and mating. FEBS Lett (1997) 1.64
The diminished production of arachidonic acid oxygenation products by elicited mouse peritoneal macrophages: possible mechanisms. J Immunol (1980) 1.63
cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. J Neurosci (1999) 1.63
Evidence for two sources of arachidonic acid for oxidative metabolism by mouse peritoneal macrophages. J Biol Chem (1982) 1.63
Alz 50, a monoclonal antibody to Alzheimer's disease antigen, cross-reacts with tau proteins from bovine and normal human brain. J Biol Chem (1988) 1.61
Purification and properties of filamin, and actin binding protein from chicken gizzard. J Biol Chem (1976) 1.60
Pathogenesis of the chronic inflammatory lesion induced by group A streptococcal cell walls. Lab Invest (1974) 1.60
Participation of mononuclear phagocytes in chronic inflammatory diseases. J Reticuloendothel Soc (1974) 1.59
CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects. Neurology (2002) 1.58
Neurofibrillary tangles and senile plaques in aged bears. J Neuropathol Exp Neurol (1988) 1.56
Is there an energy deficiency in homozygous sickle cell disease? Am J Clin Nutr (1997) 1.54
The effect of continuous lumbar epidural analgesia on the acid-base status of maternal arterial blood during the first stage of labour. J Obstet Gynaecol Br Commonw (1973) 1.53
Diffuse Lewy body disease: light and electron microscopic immunocytochemistry of senile plaques. Acta Neuropathol (1989) 1.52
Cost implications of using an atraumatic dressing in the treatment of acute wounds. J Wound Care (2008) 1.51
Ballooned neurons in select neurodegenerative diseases contain phosphorylated neurofilament epitopes. Acta Neuropathol (1986) 1.50